Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 211 AL 225

Alzheimer's disease: a report from the 7th Kuopio Alzheimer symposium

Haapasalo A, Pikkarainen M, Soininen H.

Neurodegener Dis Manag. 2015 Oct;5(5):379-82. doi: 10.2217/nmt.15.31. Epub 2015 Oct 19.

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP.

Lancet Neurol. 2015 Dec;14(12):1171-81. doi: 10.1016/S1474-4422(15)00258-6. Epub 2015 Oct 27.

[A comparison of the efficacy and safety of memantal and original memantine in the treatment of mild and moderate dementia in Alzheimer's disease]

Shiryaev OY, Shapovalov DL, Polozova TM, Goncharova OV, Kuznetsova NA, Cherenkova EV, Fedorova EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):56-61. doi: 10.17116/jnevro201511510156-61.

Novel potential for the management of Alzheimer disease

Ginter E, Simko V, Weinrebova D, Ladecka Z.

Bratisl Lek Listy. 2015;116(10):580-1. doi: 10.4149/bll_2015_112.

Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial

Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, Farlow MR.

Neurology. 2015 Dec 1;85(22):1937-44. doi: 10.1212/WNL.0000000000002171. Epub 2015 Nov 4.

Alzheimer dementia--a problem of individuals, families, medicine and society

Kostić S.

Vojnosanit Pregl. 2015 Sep;72(9):763-4. doi: 10.2298/vsp1509763k.

The Effects of Aerobic Exercise on Cognitive Function of Alzheimer's Disease Patients

Yang SY, Shan CL, Qing H, Wang W, Zhu Y, Yin MM, Machado S, Yuan TF, Wu T.

CNS Neurol Disord Drug Targets. 2015;14(10):1292-7. doi: 10.2174/1871527315666151111123319.

Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?

Portugal EM, Vasconcelos PG, Souza R, Lattari E, Monteiro-Junior RS, Machado S, Deslandes AC.

CNS Neurol Disord Drug Targets. 2015;14(9):1209-13. doi: 10.2174/1871527315666151111121749.

An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy

Ashraf GM, Tabrez S, Jabir NR, Firoz CK, Ahmad S, Hassan I, Alexiou A, Kamal MA.

Curr Drug Metab. 2015;16(8):719-27. doi: 10.2174/138920021608151107125757.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

The APOE genotype: modification of therapeutic responses in Alzheimer's disease

Hanson AJ, Craft S, Banks WA.

Curr Pharm Des. 2015;21(1):114-20. doi: 10.2174/1381612820666141020164222.

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.

J Alzheimers Dis. 2015;44(3):897-906. doi: 10.3233/JAD-141791.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias